Gyroscope Therapeutics’ $148.0 Million Series C Equity Financing

Davis Polk advised Gyroscope Therapeutics Limited on the deal.Gyroscope Therapeutics Limited executed its $148 million private placement of Series C preferred shares. The financing was led…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here